MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,313,203
Unit: Dollar
Positive Cash Flow Breakdown
Accrued expenses
Stock-based compensation
Amortization of loan commitment ...
Negative Cash Flow Breakdown
Net loss
Accounts payable
Grant receivable
Prepaid expenses
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-12-31
2025-09-30
2025-06-30
Net loss
-1,999,397
-2,158,354
-8,484,763
Stock-based compensation
198,530
237,644
1,446,824
Amortization of loan commitment fee
17,439
17,440
382,014
Grant receivable
-46,958
63,393
-73,218
Prepaid expenses
4,642
-90,668
-152,351
Accounts payable
-52,677
383,364
67,749
Accrued expenses
574,502
92,769
159,356
Net cash used in operating activities
-1,313,203
-1,273,076
-6,349,687
Proceeds from issuance of common stock
-
-
15,000,000
Payment of financing/offering costs
-
-
116,664
Net cash provided by (used in) financing activities
-
-
14,883,336
Net (decrease) increase in cash
-1,313,203
-1,273,076
8,533,649
Cash and cash equivalents at beginning of period
10,354,773
11,627,849
3,094,200
Cash and cash equivalents at end of period
9,041,570
10,354,773
11,627,849
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net (decrease)
increase in cash
-$1,313,203
Accrued expenses
$574,502
Stock-based compensation
$198,530
Amortization of loan
commitment fee
$17,439
Net cash used in
operating activities
-$1,313,203
Canceled cashflow
$790,471
Net loss
-$1,999,397
Accounts payable
-$52,677
Grant receivable
-$46,958
Prepaid expenses
$4,642
Buy us a coffee
Anebulo Pharmaceuticals, Inc. (ANEB)
Anebulo Pharmaceuticals, Inc. (ANEB)